Zebra Capital Management LLC Simulations Plus, Inc. Transaction History

Zebra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$60.06 - $89.52 $562,461 - $838,354	-9,365 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$53.26 - $77.18 $75,203 - $108,978	-1,412 Reduced 13.1%	9,365 $673,000
Q3 2020 Nov 16, 2020	BUY	$57.51 - $75.36 $51,356 - $67,296	893 Added 9.03%	10,777 $812,000
Q2 2020 Aug 14, 2020	SELL	$32.91 - $59.82 $50,253 - $91,345	-1,527 Reduced 13.38%	9,884 $591,000
Q1 2020 May 15, 2020	BUY	$26.79 - $38.99 $51,276 - $74,626	1,914 Added 20.15%	11,411 $399,000
Q4 2019 Feb 14, 2020	BUY	$29.07 - $35.63 $276,077 - $338,378	9,497 New	9,497 $277,000

179

15.9M

3.9K

200

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $614M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.